Loading clinical trials...
Loading clinical trials...
The investigators have developed an image analysis method that can predict the likelihood that a patient with age related macular degeneration (AMD) will progress within 1 year, based on computerized ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Stanford University
NCT01496625 · Age-Related Macular Degeneration, Diabetic Retinopathy, and more
NCT06990269 · Geographic Atrophy Secondary to Age-related Macular Degeneration
NCT07587515 · Neovascular (Wet) Age-Related Macular Degeneration
NCT05803785 · Age-Related Macular Degeneration
NCT06593405 · Age-Related Macular Degeneration
Byers Eye Institute at Stanford
Palo Alto, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions